DE60233654D1 - Dimerisierter t-zell rezeptor fragment, dessen zusammensetzungen und verwendung - Google Patents

Dimerisierter t-zell rezeptor fragment, dessen zusammensetzungen und verwendung

Info

Publication number
DE60233654D1
DE60233654D1 DE60233654T DE60233654T DE60233654D1 DE 60233654 D1 DE60233654 D1 DE 60233654D1 DE 60233654 T DE60233654 T DE 60233654T DE 60233654 T DE60233654 T DE 60233654T DE 60233654 D1 DE60233654 D1 DE 60233654D1
Authority
DE
Germany
Prior art keywords
interleukin
cell receptor
following infection
progression
aids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60233654T
Other languages
English (en)
Inventor
John Jacob Marchalonis
Ronald Ross Watson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Arizona
Original Assignee
University of Arizona
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Arizona filed Critical University of Arizona
Application granted granted Critical
Publication of DE60233654D1 publication Critical patent/DE60233654D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503Immunoglobulin superfamily
    • C07K14/7051T-cell receptor (TcR)-CD3 complex
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Confectionery (AREA)
DE60233654T 2001-05-18 2002-05-17 Dimerisierter t-zell rezeptor fragment, dessen zusammensetzungen und verwendung Expired - Lifetime DE60233654D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0112126.8A GB0112126D0 (en) 2001-05-18 2001-05-18 Composition
PCT/GB2002/002323 WO2002094860A2 (en) 2001-05-18 2002-05-17 Dimerized t-cell receptor fragment, its compositions and use

Publications (1)

Publication Number Publication Date
DE60233654D1 true DE60233654D1 (de) 2009-10-22

Family

ID=9914850

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60233654T Expired - Lifetime DE60233654D1 (de) 2001-05-18 2002-05-17 Dimerisierter t-zell rezeptor fragment, dessen zusammensetzungen und verwendung

Country Status (7)

Country Link
US (1) US7998926B2 (de)
EP (1) EP1389219B1 (de)
AT (1) ATE442387T1 (de)
AU (1) AU2002302751A1 (de)
DE (1) DE60233654D1 (de)
GB (1) GB0112126D0 (de)
WO (1) WO2002094860A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7323174B1 (en) * 2000-06-12 2008-01-29 Arizona Board Of Regents On Behalf Of The University Of Arizona Modulation of immune response and methods based thereon
WO2005087793A2 (en) 2004-02-05 2005-09-22 The Arizona Board Of Regents, A Body Corporate Acting On Behalf Of Arizona State University Immunostimulatory compositions and uses thereof
BRPI0509497B1 (pt) 2004-03-30 2022-07-19 Institut Gustave Roussy Seqüência de polipeptídeos envolvida na modulação do efeito imunosupressor de proteínas virais
WO2005115430A1 (en) * 2004-05-27 2005-12-08 Gropep Limited Treatment of inflammatory airway disease
US8178649B2 (en) * 2004-12-07 2012-05-15 Arizona Biomedical Research Commission Immunostimulatory compositions and uses thereof
US7811995B2 (en) * 2006-12-13 2010-10-12 Susavion Biosciences, Inc. Therapeutic and diagnostic peptides
US8496942B2 (en) * 2006-12-13 2013-07-30 Susavion Biosciences, Inc. Therapeutic peptides and uses thereof
EP3288576A4 (de) 2015-04-27 2019-01-16 Susavion Biosciences, Inc. Zusammensetzungen und verfahren zur behandlung von krebs und persistenten virusinfektionen

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8205892D0 (sv) 1982-10-18 1982-10-18 Bror Morein Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
SE8405493D0 (sv) 1984-11-01 1984-11-01 Bror Morein Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
ES2039229T3 (es) 1986-01-14 1993-09-16 De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur Procedimiento para la preparacion de complejos inmunogenicos y composiciones farmaceuticas que contienen estos complejos.
US4806352A (en) 1986-04-15 1989-02-21 Ribi Immunochem Research Inc. Immunological lipid emulsion adjuvant
WO1991010736A2 (en) 1990-01-19 1991-07-25 Dana Farber Cancer Institute CLONING AND CHARACTERIZATION OF THE CD3θ SUBUNIT
WO1992001715A1 (en) 1990-07-19 1992-02-06 The Board Of Trustees Of The Leland Stanford Junior University Soluble cell-surface dimeric proteins
CZ206195A3 (en) * 1993-02-12 1996-04-17 Univ Leland Stanford Junior Controlled transcription of target genes and other biological materials
AUPM322393A0 (en) 1993-12-24 1994-01-27 Austin Research Institute, The Mucin carbohydrate compounds and their use in immunotherapy
WO1996021028A2 (en) 1995-01-03 1996-07-11 Procept, Inc. Soluble heterodimeric t cell receptors and their antibodies
US6150337A (en) 1996-01-23 2000-11-21 Icn Pharmaceuticals, Inc. Specific modulation of Th1/Th2 cytokine expression by Ribavirin in activated T-lymphocytes
US5714577A (en) * 1996-01-26 1998-02-03 University Of Pittsburgh Antimicrobial peptides
EP0889964A1 (de) 1996-03-28 1999-01-13 The Johns Hopkins University Lösliche divalente und multivalente heterodimäre proteinanalogen
US5962319A (en) 1997-05-19 1999-10-05 Bml, Inc. Human-Th1-specific protein, gene encoding the protein, transformants, recombinant vectors, and antibodies related to the gene
US5911990A (en) * 1996-08-13 1999-06-15 Arizona Board Of Regents On Behalf Of The University Of Arizona T-cell receptor peptides and methods for preventing the progression to AIDS in an animal model
IL119938A (en) * 1996-12-30 2005-08-31 Yissum Res Dev Co Peptides capable of eliciting protective immunity against toxic shock induced by pyrogenic exotoxins or of antagonizing toxin-mediated activation of t cells
US7323174B1 (en) * 2000-06-12 2008-01-29 Arizona Board Of Regents On Behalf Of The University Of Arizona Modulation of immune response and methods based thereon

Also Published As

Publication number Publication date
US20040248192A1 (en) 2004-12-09
WO2002094860A3 (en) 2003-06-26
ATE442387T1 (de) 2009-09-15
WO2002094860A2 (en) 2002-11-28
GB0112126D0 (en) 2001-07-11
EP1389219A2 (de) 2004-02-18
US7998926B2 (en) 2011-08-16
EP1389219B1 (de) 2009-09-09
AU2002302751A1 (en) 2002-12-03

Similar Documents

Publication Publication Date Title
RS20130234A1 (en) Therapeutic human anti-il-1r1 monoclonal antibody
HK1088840A1 (en) Stable analogs of glp-1 glp-1
WO2006023665A3 (en) Il-1 antagonist formulations
IL141021A (en) Use of copolymer-like polypeptide-1 to prepare a drug to treat autoimmune diseases
WO2006034334A3 (en) Peptide analogs capable of enhancing stimulation of a glioma-specific ctl response
JP2004518624A5 (de)
DK1278534T3 (da) Fremgangsmåder og sammensætninger til svækkelse af multiplikationen af HIV-1
AU6285694A (en) Therapeutical compositions for use in humans, characterised by a combination of a muramyl peptide and a cytokine
CA2106762A1 (en) Bradykinin Antagonist Peptides
DE60233654D1 (de) Dimerisierter t-zell rezeptor fragment, dessen zusammensetzungen und verwendung
YU394A (sh) Novi peptidi koji deluju kao antagonisti opijatskih receptora i postupci za njihovu izradu
DK1447414T3 (da) Antagonistpeptider af carcinoembronisk antigen (CEA)
KR980002066A (ko) 변이형 인간 성장호르몬 및 그의 용도
ES2123556T3 (es) Peptidos de tipo bradiquinina.
WO2005072766A3 (en) Peptides that bind to hsp90 proteins
GB9501826D0 (en) Polypeptide fragments
EP1250358B1 (de) Therapeutische peptide
ATE467421T1 (de) Cytokine und cytokinrezeptoren mit reduzierter immunogenität
EP1908781A3 (de) Modulation der Immunreaktion und darauf basierende Verfahren
HK1092162A1 (en) Biologically active peptides comprising isoleucyl-valyl-threonyl- asparaginyl-threonyl-threonine (ivtntt)
WO2001051512A3 (en) Human and parasite orphan receptor proteins
DE60223232D1 (de) Mucinpeptid mit immunstärkenden eigenschaften
DE60325227D1 (de)
Hamaoka T-cell-replacing factor and its acceptor site on B cells: molecular properties and immunogenetic aspects
FR2856598A1 (fr) Peptides derives de la proteine mmp-2 et leur utilisation en immunotherapie antitumorale

Legal Events

Date Code Title Description
8364 No opposition during term of opposition